Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eliava Pharmacy, officially known as Eliava Authorized Pharmacy, is a specialized pharmaceutical company based in Tbilisi, Georgia, and a key member of the Eliava Consortium. Established in 2013 by the Eliava Foundation and the Eliava Diagnostic Center, the pharmacy holds a unique license for compounding personalized bacteriophage preparations, known as autophages, tailored to individual patient needs. It serves as the primary retail and distribution point for the Eliava Institute's world-renowned phage products, including Pyo-bacteriophage and Intesti-bacteriophage. The pharmacy supports the Eliava Phage Therapy Center by providing customized treatments for antibiotic-resistant bacterial infections. Its operations are deeply rooted in over a century of phage research and application pioneered by the George Eliava Institute.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eliava Pharmacy.